413 related articles for article (PubMed ID: 9562276)
1. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
[TBL] [Abstract][Full Text] [Related]
2. TSH-receptor antibody (TSH-R Ab) variations in patients undergoing subtotal thyroidectomy for Graves' disease: a prospective study.
Rubello D; Casara D; Pelizzo MR; Girelli ME; Piotto A; Piccolo M; Busnardo B
J Nucl Biol Med (1991); 1993 Jun; 37(2):73-6. PubMed ID: 8373836
[TBL] [Abstract][Full Text] [Related]
3. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
[TBL] [Abstract][Full Text] [Related]
4. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
Palit TK; Miller CC; Miltenburg DM
J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
[TBL] [Abstract][Full Text] [Related]
6. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease.
Ku CF; Lo CY; Chan WF; Kung AW; Lam KS
ANZ J Surg; 2005 Jul; 75(7):528-31. PubMed ID: 15972039
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative course and tactics of aftercare in hyperthyroidism].
de Heer K; Schnippenkoetter I; Kortmann KB; Beeger R
Chirurg; 1984 Mar; 55(3):171-3. PubMed ID: 6546914
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: case control study by remnant-weight matched-pair analysis.
Ozaki O; Ito K; Mimura T; Sugino K; Ito K
Thyroid; 1997 Aug; 7(4):555-9. PubMed ID: 9292942
[TBL] [Abstract][Full Text] [Related]
11. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
12. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
13. Thyroidectomy remains an effective treatment option for Graves' disease.
Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
[TBL] [Abstract][Full Text] [Related]
14. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
[TBL] [Abstract][Full Text] [Related]
15. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
16. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves' disease.
Kasuga Y; Sugenoya A; Kobayashi S; Shimizu T; Onuma H; Shingu K; Asanuma K; Hama Y; Iida F
J Am Coll Surg; 1994 Jun; 178(6):589-94. PubMed ID: 7910771
[TBL] [Abstract][Full Text] [Related]
17. Thyroidectomy for Graves' disease: is hypothyroidism inevitable?
Davenport M; Talbot CH
Ann R Coll Surg Engl; 1989 Mar; 71(2):87-91. PubMed ID: 2705732
[TBL] [Abstract][Full Text] [Related]
18. [Serum thyrotropin binding inhibitory immunoglobulin (TBII) activity before and after subtotal thyroidectomy in Grave's disease].
Hoshi T; Watanabe I; Endo S
Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1538-45. PubMed ID: 2867461
[TBL] [Abstract][Full Text] [Related]
19. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
Kuma K; Matsuzuka F; Kobayashi A; Hirai K; Fukata S; Tamai H; Miyauci A; Sugawara M
Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
[TBL] [Abstract][Full Text] [Related]
20. Extensive thyroidectomy in Graves' disease.
Gaujoux S; Leenhardt L; Trésallet C; Rouxel A; Hoang C; Jublanc C; Chigot JP; Menegaux F
J Am Coll Surg; 2006 Jun; 202(6):868-73. PubMed ID: 16735199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
